Any feedback?
Literature summary for 3.4.24.18 extracted from
- Meprins A and B (1995), Methods Enzymol., 248, 325-345.
Cloned(Commentary)
| Cloned (Comment) | Organism |
|---|---|
| mouse | Mus musculus |
| mouse | Homo sapiens |
| mouse | Rattus norvegicus |
Inhibitors
| Inhibitors | Comment | Organism | Structure |
|---|---|---|---|
| 1,10-phenanthroline | - |
Homo sapiens |  |
| 1,10-phenanthroline | - |
Mus musculus | |
| 1,10-phenanthroline | - |
Rattus norvegicus | |
| 2-mercaptoethanol | - |
Homo sapiens | |
| 2-mercaptoethanol | - |
Mus musculus | |
| 2-mercaptoethanol | - |
Rattus norvegicus | |
| Acetyl-Arg-Pro-Gly-Tyr hydroxamate | kinetics | Mus musculus | |
| actinonin | i.e. 3-[[1-[[2-(hydroxymethyl)-1-pyrolidinyl]carbonyl]-2-methylpropyl]carbamoyl]octano hydroxamic acid, strong, kinetics | Mus musculus | |
| Arg-Pro-Pro-Gly-(4-nitro)Phe-Glu-Pro-Phe-Arg | - |
Mus musculus | |
| captopril | not | Homo sapiens | |
| captopril | not | Mus musculus | |
| captopril | not | Rattus norvegicus | |
| cysteine | - |
Homo sapiens | |
| cysteine | - |
Mus musculus | |
| cysteine | - |
Rattus norvegicus | |
| EDTA | reversed by Zn2+ | Homo sapiens | |
| EDTA | reversed by Zn2+ | Mus musculus | |
| EDTA | reversed by Zn2+ | Rattus norvegicus | |
| Hydroxamyl-succinyl-Pro-Phe-Arg | kinetics | Mus musculus | |
| additional information | 3,4-dichloroisocoumarin; iodoacetate; no inhibition by phosphoramidon; PMSF, pepstatin; soybean trypsin inhibitor | Homo sapiens | |
| additional information | 3,4-dichloroisocoumarin; iodoacetate; no inhibition by phosphoramidon; PMSF, pepstatin; soybean trypsin inhibitor | Mus musculus | |
| additional information | 3,4-dichloroisocoumarin; iodoacetate; no inhibition by phosphoramidon; PMSF, pepstatin; soybean trypsin inhibitor | Rattus norvegicus |
KM Value [mM]
| KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
|---|---|---|---|---|---|
| 0.174 | - |
Arg-Pro-Pro-Gly-(4-nitro)Phe-Arg-Pro-Phe-Arg | - |
Mus musculus | |
| 0.182 | - |
Arg-Pro-Pro-Gly-(4-nitro)Phe-Lys-Pro-Phe-Arg | - |
Mus musculus | |
| 0.183 | - |
2-Aminobenzoyl-Arg-Hyp-Gly-Phe-Ser-Pro-(4-nitro)Phe-Arg | - |
Mus musculus | |
| 0.22 | - |
2-Aminobenzoyl-Arg-Gly-Pro-Phe-Ser-Pro-(4-nitro)Phe-Arg | - |
Mus musculus | |
| 0.226 | - |
Arg-Pro-Pro-Gly-(4-nitro)Phe-Phe-Pro-Phe-Arg | - |
Mus musculus | |
| 0.29 | - |
Arg-Pro-Pro-Gly-(4-nitro)Phe-Ser-Pro-Phe-Arg | - |
Mus musculus | |
| 0.296 | - |
2-Aminobenzoyl-Arg-Pro-Ile-Phe-Ser-Pro-(4-nitro)Phe-Arg | - |
Mus musculus | |
| 0.331 | - |
Arg-Pro-Pro-Gly-(4-nitro)Phe-Ala-Pro-Phe-Arg | - |
Mus musculus | |
| 0.402 | - |
2-Aminobenzoyl-Arg-Pro-Gly-Lys-Ser-Pro-(4-nitro)Phe-Arg | - |
Mus musculus | |
| 1.22 | - |
2-Aminobenzoyl-Arg-Pro-Gly-Glu-Ser-Pro-(4-nitro)Phe-Arg | - |
Mus musculus | |
| 1.38 | - |
2-Aminobenzoyl-Arg-Pro-Gly-Ala-Ser-Pro-(4-nitro)Phe-Arg | - |
Mus musculus | |
| 2.46 | - |
2-Aminobenzoyl-Arg-Pro-Gly-Leu-Ser-Pro-(4-nitro)Phe-Arg | - |
Mus musculus | |
Localization
| Localization | Comment | Organism | GeneOntology No. | Textmining |
|---|---|---|---|---|
| membrane | - |
Homo sapiens | 16020 | - |
| membrane | renal brush border membrane | Mus musculus | 16020 | - |
| membrane | renal brush border membrane | Rattus norvegicus | 16020 | - |
Metals/Ions
| Metals/Ions | Comment | Organism | Structure |
|---|---|---|---|
| Calcium | metalloendopeptidase | Mus musculus | |
| Calcium | metalloendopeptidase | Homo sapiens | |
| Calcium | metalloendopeptidase | Rattus norvegicus | |
| Calcium | 3 mol calcium per mol subunit (atomic absorption spectroscopy) | Mus musculus | |
| Calcium | 3 mol calcium per mol subunit (atomic absorption spectroscopy) | Homo sapiens | |
| Calcium | 3 mol calcium per mol subunit (atomic absorption spectroscopy) | Rattus norvegicus | |
| Calcium | Ca2+ reactivates inactive apoenzyme | Mus musculus | |
| Calcium | Ca2+ reactivates inactive apoenzyme | Homo sapiens | |
| Calcium | Ca2+ reactivates inactive apoenzyme | Rattus norvegicus | |
| additional information | Cu2+ does not reactivate inactive apoenzyme | Mus musculus | |
| additional information | Cu2+ does not reactivate inactive apoenzyme | Homo sapiens | |
| additional information | Cu2+ does not reactivate inactive apoenzyme | Rattus norvegicus | |
| Zinc | metalloendopeptidase | Mus musculus | |
| Zinc | metalloendopeptidase | Homo sapiens | |
| Zinc | metalloendopeptidase | Rattus norvegicus | |
| Zinc | 1 mol zinc per mol subunit (atomic absorption spectroscopy) | Mus musculus | |
| Zinc | zinc binding motif | Mus musculus | |
| Zinc | zinc binding motif | Homo sapiens | |
| Zinc | zinc binding motif | Rattus norvegicus | |
| Zinc | Zn2+ reactivates inactive apoenzyme | Mus musculus | |
| Zinc | Zn2+ reactivates inactive apoenzyme | Homo sapiens | |
| Zinc | Zn2+ reactivates inactive apoenzyme | Rattus norvegicus | |
Molecular Weight [Da]
| Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
|---|---|---|---|
| additional information | - |
- |
Homo sapiens |
| additional information | - |
amino acid sequence, domain structure and tertiary structure deduced from cDNAs | Mus musculus |
| additional information | - |
amino acid sequence, domain structure and tertiary structure deduced from cDNAs | Rattus norvegicus |
| 85000 | - |
4 * 85000, mouse | Mus musculus |
| 85000 | - |
4 * 85000, mouse | Rattus norvegicus |
| 90000 | - |
x * 90000, mouse, SDS-PAGE, reducing conditions | Mus musculus |
| 90000 | - |
x * 90000, mouse, SDS-PAGE, reducing conditions | Rattus norvegicus |
| 270000 | 320000 | mouse, gel filtration | Mus musculus |
| 320000 | - |
mouse, gel filtration, SDS-PAGE in the absence of 2-mercaptoethanol | Mus musculus |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | - |
PPH | - |
| Homo sapiens PPH | - |
PPH | - |
| Mus musculus | - |
random bred ICR and at least 35 inbred, recombinant and congenic strains | - |
| Rattus norvegicus | - |
- |
- |
Posttranslational Modification
| Posttranslational Modification | Comment | Organism |
|---|---|---|
| glycoprotein | no sialic acid | Mus musculus |
| glycoprotein | no sialic acid | Homo sapiens |
| glycoprotein | no sialic acid | Rattus norvegicus |
Purification (Commentary)
| Purification (Comment) | Organism |
|---|---|
- |
Mus musculus |
Specific Activity [micromol/min/mg]
| Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
|---|---|---|---|
| additional information | - |
3.25-13 mg azocasein/min/mg | Mus musculus |
| additional information | - |
3.25-13 mg azocasein/min/mg | Homo sapiens |
| additional information | - |
3.25-13 mg azocasein/min/mg | Rattus norvegicus |
Storage Stability
| Storage Stability | Organism |
|---|---|
| -20°C, 1 mg enzyme/ml, more than a year with little loss of activity | Mus musculus |
| 4°C, 1 mg enzyme/ml at least 2 weeks with little loss of activity | Mus musculus |
Substrates and Products (Substrate)
| Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| 2-aminobenzoyl-Arg-Gly-Pro-Phe-Ser-Pro-(4-nitro)Phe-Arg + H2O | fluorogenic bradykinin analog substrate, cleavage site: Phe-Ser | Mus musculus | 2-aminobenzoyl-Arg-Gly-Pro-Phe + Ser-Pro-(4-nitro)Phe-Arg | - |
? | |
| 2-aminobenzoyl-Arg-Hyp-Gly-Phe-Ser-Pro-(4-nitro)Phe-Arg + H2O | fluorogenic bradykinin analog substrate, cleavage site: Phe-Ser | Mus musculus | 2-aminobenzoyl-Arg-Hyp-Gly-Phe + Ser-Pro-(4-nitro)Phe-Arg | - |
? | |
| 2-aminobenzoyl-Arg-Pro-Gly-Ala-Ser-Pro-(4-nitro)Phe-Arg + H2O | fluorogenic bradykinin analog substrate, cleavage site: Ala-Ser | Mus musculus | 2-aminobenzoyl-Arg-Pro-Gly-Ala + Ser-Pro-(4-nitro)Phe-Arg | - |
? | |
| 2-aminobenzoyl-Arg-Pro-Gly-Glu-Ser-Pro-(4-nitro)Phe-Arg + H2O | fluorogenic bradykinin analog substrate, cleavage site: Glu-Ser | Mus musculus | 2-aminobenzoyl-Arg-Pro-Gly-Glu + Ser-Pro-(4-nitro)Phe-Arg | - |
? | |
| 2-aminobenzoyl-Arg-Pro-Gly-Leu-Ser-Pro-(4-nitro)Phe-Arg + H2O | fluorogenic bradykinin analog substrate, cleavage sites: Leu-Ser (major site) and Gly-Leu | Mus musculus | 2-aminobenzoyl-Arg-Pro-Gly-Leu + Ser-Pro-(4-nitro)Phe-Arg | major products | ? | |
| 2-aminobenzoyl-Arg-Pro-Gly-Lys-Ser-Pro-(4-nitro)Phe-Arg + H2O | fluorogenic bradykinin analog substrate, cleavage sites: Gly-Lys (major site) and Lys-Ser | Mus musculus | 2-aminobenzoyl-Arg-Pro-Gly + Lys-Ser-Pro-(4-nitro)Phe-Arg | major products | ? | |
| 2-aminobenzoyl-Arg-Pro-Ile-Phe-Ser-Pro-(4-nitro)Phe-Arg + H2O | fluorogenic bradykinin analog substrates, cleavage site: Phe-Ser | Mus musculus | 2-aminobenzoyl-Arg-Pro-Ile-Phe + Ser-Pro-(4-nitro)Phe-Arg | - |
? | |
| alpha-melanocyte stimulating hormone + H2O | i.e. acetyl-Ser-Tyr-Ser-Met-Gly-His-Phe-Arg-Trp-Gly-Lys-Pro-Val, cleavage sites: Ser-Met, Gly-Lys, mouse | Mus musculus | ? | - |
? | |
| angiotensin I + H2O | i.e. Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu, cleavage site: Tyr-Ile | Mus musculus | Asp-Arg-Val-Tyr + Ile-His-Pro-Phe + Ile-His-Pro-Phe-His-Leu | - |
? | |
| angiotensin I + H2O | i.e. Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu, cleavage site: Tyr-Ile | Homo sapiens | Asp-Arg-Val-Tyr + Ile-His-Pro-Phe + Ile-His-Pro-Phe-His-Leu | - |
? | |
| angiotensin I + H2O | i.e. Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu, cleavage site: Tyr-Ile | Rattus norvegicus | Asp-Arg-Val-Tyr + Ile-His-Pro-Phe + Ile-His-Pro-Phe-His-Leu | - |
? | |
| angiotensin II + H2O | cleavage site: Tyr-Ile | Mus musculus | Asp-Arg-Val-Tyr + Ile-His-Pro-Phe | - |
? | |
| angiotensin II + H2O | cleavage site: Tyr-Ile | Homo sapiens | Asp-Arg-Val-Tyr + Ile-His-Pro-Phe | - |
? | |
| angiotensin II + H2O | cleavage site: Tyr-Ile | Rattus norvegicus | Asp-Arg-Val-Tyr + Ile-His-Pro-Phe | - |
? | |
| angiotensin II + H2O | i.e. Asp-Arg-Val-Tyr-Ile-His-Pro-Phe | Mus musculus | Asp-Arg-Val-Tyr + Ile-His-Pro-Phe | - |
? | |
| angiotensin II + H2O | i.e. Asp-Arg-Val-Tyr-Ile-His-Pro-Phe | Homo sapiens | Asp-Arg-Val-Tyr + Ile-His-Pro-Phe | - |
? | |
| angiotensin II + H2O | i.e. Asp-Arg-Val-Tyr-Ile-His-Pro-Phe | Rattus norvegicus | Asp-Arg-Val-Tyr + Ile-His-Pro-Phe | - |
? | |
| angiotensin III + H2O | i.e. Arg-Val-Tyr-Ile-His-Pro-Phe, cleavage site: Tyr-Ile | Mus musculus | Arg-Val-Tyr + Ile-His-Pro-Phe | - |
? | |
| angiotensin III + H2O | i.e. Arg-Val-Tyr-Ile-His-Pro-Phe, cleavage site: Tyr-Ile | Homo sapiens | Arg-Val-Tyr + Ile-His-Pro-Phe | - |
? | |
| angiotensin III + H2O | i.e. Arg-Val-Tyr-Ile-His-Pro-Phe, cleavage site: Tyr-Ile | Rattus norvegicus | Arg-Val-Tyr + Ile-His-Pro-Phe | - |
? | |
| Arg-Pro-Pro-Gly-(4-nitro)Phe-Ala-Pro-Phe-Arg + H2O | chromogenic bradykinin analog | Mus musculus | Arg-Pro-Pro-Gly-(4-nitro)Phe + Ala-Pro-Phe-Arg | - |
? | |
| Arg-Pro-Pro-Gly-(4-nitro)Phe-Arg-Pro-Phe-Arg + H2O | chromogenic bradykinin analog | Mus musculus | Arg-Pro-Pro-Gly-(4-nitro)Phe + Arg-Pro-Phe-Arg | - |
? | |
| Arg-Pro-Pro-Gly-(4-nitro)Phe-Lys-Pro-Phe-Arg + H2O | chromogenic bradykinin analog | Mus musculus | Arg-Pro-Pro-Gly-(4-nitro)Phe + Lys-Pro-Phe-Arg | - |
? | |
| Arg-Pro-Pro-Gly-(4-nitro)Phe-Phe-Pro-Phe-Arg + H2O | chromogenic bradykinin analog | Mus musculus | Arg-Pro-Pro-Gly-(4-nitro)Phe + Phe-Pro-Phe-Arg | - |
? | |
| Arg-Pro-Pro-Gly-(4-nitro)Phe-Ser-Pro-Phe-Arg + H2O | i.e. nitrobradykinin, chromogenic bradykinin analog | Mus musculus | Arg-Pro-Pro-Gly-(4-nitro)Phe + Ser-Pro-Phe-Arg | - |
? | |
| azocasein + H2O | excellent substrate for mouse, poorer substrate for rat and human enzymes | Mus musculus | fragments of azocasein | - |
? | |
| azocasein + H2O | excellent substrate for mouse, poorer substrate for rat and human enzymes | Homo sapiens | fragments of azocasein | - |
? | |
| azocasein + H2O | excellent substrate for mouse, poorer substrate for rat and human enzymes | Rattus norvegicus | fragments of azocasein | - |
? | |
| azocasein + H2O | excellent substrate for mouse, poorer substrate for rat and human enzymes | Homo sapiens PPH | fragments of azocasein | - |
? | |
| Big endothelin I + H2O | rat | Rattus norvegicus | ? | - |
? | |
| bradykinin + H2O | - |
Mus musculus | Arg-Pro-Pro-Gly + Phe-Ser-Pro-Phe-Arg | - |
? | |
| bradykinin + H2O | - |
Homo sapiens | Arg-Pro-Pro-Gly + Phe-Ser-Pro-Phe-Arg | - |
? | |
| bradykinin + H2O | - |
Rattus norvegicus | Arg-Pro-Pro-Gly + Phe-Ser-Pro-Phe-Arg | - |
? | |
| Endothelin I + H2O | rat | Rattus norvegicus | ? | - |
? | |
| Gonadotropin + H2O | mouse | Mus musculus | ? | - |
? | |
| Human alpha-atrial natiuretic peptide + H2O | rat | Rattus norvegicus | ? | - |
? | |
| Human transforming growth factor + H2O | rat | Rattus norvegicus | ? | - |
? | |
| Insulin B-chain + H2O | prevalent cleavage sites are Gly20-Glu21, Phe24-Phe25 and Phe25-Tyr26 | Mus musculus | Hydrolyzed insulin B-chain | - |
? | |
| Insulin B-chain + H2O | prevalent cleavage sites are Gly20-Glu21, Phe24-Phe25 and Phe25-Tyr26 | Homo sapiens | Hydrolyzed insulin B-chain | - |
? | |
| Insulin B-chain + H2O | prevalent cleavage sites are Gly20-Glu21, Phe24-Phe25 and Phe25-Tyr26 | Rattus norvegicus | Hydrolyzed insulin B-chain | - |
? | |
| Insulin B-chain + H2O | 10 cleavage sites | Mus musculus | Hydrolyzed insulin B-chain | - |
? | |
| Insulin B-chain + H2O | 10 cleavage sites | Homo sapiens | Hydrolyzed insulin B-chain | - |
? | |
| Insulin B-chain + H2O | 10 cleavage sites | Rattus norvegicus | Hydrolyzed insulin B-chain | - |
? | |
| Insulin B-chain + H2O | 7 major and 3 minor sites | Mus musculus | Hydrolyzed insulin B-chain | - |
? | |
| Insulin B-chain + H2O | 7 major and 3 minor sites | Homo sapiens | Hydrolyzed insulin B-chain | - |
? | |
| Insulin B-chain + H2O | 7 major and 3 minor sites | Rattus norvegicus | Hydrolyzed insulin B-chain | - |
? | |
| Insulin B-chain + H2O | oxidized form | Mus musculus | Hydrolyzed insulin B-chain | - |
? | |
| Insulin B-chain + H2O | oxidized form | Homo sapiens | Hydrolyzed insulin B-chain | - |
? | |
| Insulin B-chain + H2O | oxidized form | Rattus norvegicus | Hydrolyzed insulin B-chain | - |
? | |
| Insulin B-chain + H2O | prevalent cleavage sites are Gly20-Glu21, Phe24-Phe25 and Phe25-Tyr26 | Homo sapiens PPH | Hydrolyzed insulin B-chain | - |
? | |
| Insulin B-chain + H2O | 10 cleavage sites | Homo sapiens PPH | Hydrolyzed insulin B-chain | - |
? | |
| Insulin B-chain + H2O | 7 major and 3 minor sites | Homo sapiens PPH | Hydrolyzed insulin B-chain | - |
? | |
| Insulin B-chain + H2O | oxidized form | Homo sapiens PPH | Hydrolyzed insulin B-chain | - |
? | |
| N-Benzoyl-L-tyrosyl-4-aminobenzoate + H2O | i.e. PABA-peptide, rat, human, arylamidolysis | Homo sapiens | N-Benzoyl-L-tyrosine + 4-aminobenzoate | - |
? | |
| N-Benzoyl-L-tyrosyl-4-aminobenzoate + H2O | i.e. PABA-peptide, rat, human, arylamidolysis | Rattus norvegicus | N-Benzoyl-L-tyrosine + 4-aminobenzoate | - |
? | |
| neurotensin + H2O | i.e. pyro-Glu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu, mouse, rat, cleavage sites: Glu-Asn, Asn-Lys | Mus musculus | ? | - |
? | |
| neurotensin + H2O | i.e. pyro-Glu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu, mouse, rat, cleavage sites: Glu-Asn, Asn-Lys | Rattus norvegicus | ? | - |
? | |
| Substance P + H2O | - |
Homo sapiens | Hydrolyzed substance P | - |
? | |
| Substance P + H2O | rat | Rattus norvegicus | Hydrolyzed substance P | - |
? | |
| [Met5]enkephalin-Arg6-Phe7 + H2O | - |
Mus musculus | ? | - |
? | |
| [Met5]enkephalin-Arg6-Phe7 + H2O | - |
Homo sapiens | ? | - |
? | |
| [Met5]enkephalin-Arg6-Phe7 + H2O | - |
Rattus norvegicus | ? | - |
? | |
Subunits
| Subunits | Comment | Organism |
|---|---|---|
| More | the mouse enzyme is composed of disulfide linked dimers associating non-covalently to form tetramers and sometimes higher order oligomers | Mus musculus |
| More | the mouse enzyme is composed of disulfide linked dimers associating non-covalently to form tetramers and sometimes higher order oligomers | Rattus norvegicus |
| oligomer | x * 90000, mouse, SDS-PAGE, reducing conditions | Mus musculus |
| oligomer | x * 90000, mouse, SDS-PAGE, reducing conditions | Rattus norvegicus |
| tetramer | 4 * 85000, mouse | Mus musculus |
| tetramer | 4 * 85000, mouse | Rattus norvegicus |
| tetramer | in the presence of 2-mercaptoethanol | Mus musculus |
| tetramer | in the presence of 2-mercaptoethanol | Rattus norvegicus |
Temperature Optimum [°C]
| Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
|---|---|---|---|
| 30 | - |
assay at | Mus musculus |
| 30 | - |
nitrobradykinin assay | Mus musculus |
| 37 | - |
assay at | Mus musculus |
| 37 | - |
assay at | Homo sapiens |
| 37 | - |
assay at | Rattus norvegicus |
Turnover Number [1/s]
| Turnover Number Minimum [1/s] | Turnover Number Maximum [1/s] | Substrate | Comment | Organism | Structure |
|---|---|---|---|---|---|
| 1.1 | - |
2-Aminobenzoyl-Arg-Gly-Pro-Phe-Ser-Pro-(4-nitro)Phe-Arg | - |
Mus musculus | |
| 2.4 | - |
2-Aminobenzoyl-Arg-Pro-Gly-Lys-Ser-Pro-(4-nitro)Phe-Arg | - |
Mus musculus | |
| 4.9 | - |
2-Aminobenzoyl-Arg-Pro-Gly-Glu-Ser-Pro-(4-nitro)Phe-Arg | - |
Mus musculus | |
| 5 | - |
Arg-Pro-Pro-Gly-(4-nitro)Phe-Lys-Pro-Phe-Arg | - |
Mus musculus | |
| 7.6 | - |
Arg-Pro-Pro-Gly-(4-nitro)Phe-Phe-Pro-Phe-Arg | - |
Mus musculus | |
| 12 | - |
2-Aminobenzoyl-Arg-Pro-Gly-Leu-Ser-Pro-(4-nitro)Phe-Arg | - |
Mus musculus | |
| 19.6 | - |
Arg-Pro-Pro-Gly-(4-nitro)Phe-Arg-Pro-Phe-Arg | - |
Mus musculus | |
| 26.7 | - |
2-Aminobenzoyl-Arg-Hyp-Gly-Phe-Ser-Pro-(4-nitro)Phe-Arg | - |
Mus musculus | |
| 40.9 | - |
Arg-Pro-Pro-Gly-(4-nitro)Phe-Ser-Pro-Phe-Arg | - |
Mus musculus | |
| 51.5 | - |
Arg-Pro-Pro-Gly-(4-nitro)Phe-Ala-Pro-Phe-Arg | - |
Mus musculus | |
| 98.5 | - |
2-Aminobenzoyl-Arg-Pro-Gly-Ala-Ser-Pro-(4-nitro)Phe-Arg | - |
Mus musculus | |
| 133 | - |
2-Aminobenzoyl-Arg-Pro-Ile-Phe-Ser-Pro-(4-nitro)Phe-Arg | - |
Mus musculus | |
pH Optimum
| pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
|---|---|---|---|
| additional information | - |
pI: multiple bonds in the range of 4-5, presumably due to glycosylation | Mus musculus |
| additional information | - |
pI: multiple bonds in the range of 4-5, presumably due to glycosylation | Homo sapiens |
| additional information | - |
pI: multiple bonds in the range of 4-5, presumably due to glycosylation | Rattus norvegicus |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
